Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 May 1];9(6):s630. Available from: https://skin.dermsquared.com/skin/article/view/3919